HOOKIPA PHARMA INC's ticker is HOOK and the CUSIP is 43906K100. A total of 58 filers reported holding HOOKIPA PHARMA INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $68,867 | -32.8% | 111,797 | -4.0% | 0.00% | – |
| Q2 2023 | $102,446 | +34510.1% | 116,416 | -71.0% | 0.00% | – |
| Q1 2023 | $296 | -23.1% | 401,786 | -15.4% | 0.00% | – |
| Q4 2022 | $385 | -99.9% | 475,044 | +24.3% | 0.00% | – |
| Q3 2022 | $512,000 | -55.3% | 382,095 | -45.6% | 0.00% | -100.0% |
| Q2 2022 | $1,145,000 | +74.3% | 702,738 | +149.4% | 0.00% | – |
| Q4 2021 | $657,000 | -60.4% | 281,792 | -0.1% | 0.00% | -100.0% |
| Q3 2021 | $1,661,000 | -53.3% | 281,997 | -27.3% | 0.00% | -50.0% |
| Q2 2021 | $3,553,000 | +1142.3% | 387,917 | +1405.6% | 0.00% | – |
| Q4 2020 | $286,000 | +197.9% | 25,765 | +154.1% | 0.00% | – |
| Q3 2020 | $96,000 | -75.1% | 10,141 | -69.4% | 0.00% | -100.0% |
| Q2 2020 | $385,000 | +17.4% | 33,121 | -32.1% | 0.00% | – |
| Q2 2019 | $328,000 | – | 48,747 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 1,842,902 | $17,452,000 | 0.32% |
| Samsara BioCapital, LLC | 116,602 | $1,104,000 | 0.31% |
| Artal Group S.A. | 599,616 | $5,678,000 | 0.14% |
| HHLR ADVISORS, LTD. | 943,254 | $8,933,000 | 0.07% |
| DAFNA Capital Management LLC | 22,061 | $209,000 | 0.07% |
| Baker Brothers Advisors | 700,481 | $6,634,000 | 0.03% |
| ZACKS INVESTMENT MANAGEMENT | 72,064 | $682,000 | 0.01% |
| HOWLAND CAPITAL MANAGEMENT LLC | 14,728 | $139,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 14,374 | $139,000 | 0.00% |
| Squarepoint Ops LLC | 12,699 | $120,000 | 0.00% |